Needle-based biopsy guns are handheld devices, which include a motor assembly attached to a biopsy needle, used to collect tissue samples from a patients body to detect malignancies. These devices may be automatic, semiautomatic, or manual, with a spring-loaded mechanism for a minimally invasive insertion through the skin to obtain samples for further laboratory testing.
Needle Based Biopsy Gun Market contains market size and forecasts of Needle Based Biopsy Gun in global, including the following market information:
- Global Needle Based Biopsy Gun Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Needle Based Biopsy Gun Market Sales, 2017-2022, 2023-2028, (K Units)
- Global top five Needle Based Biopsy Gun companies in 2021 (%)
The global Needle Based Biopsy Gun market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Vacuum-Assisted Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Needle Based Biopsy Gun include C. R. Bard, Becton Dickinson and Company, Cook Group Incorporated, Leica Biosystems, Argon Medical Devices, B. Braun Melsungen, Cardinal Health, Olympus Corporation and Boston Scientific Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Needle Based Biopsy Gun manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Needle Based Biopsy Gun Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Needle Based Biopsy Gun Market Segment Percentages, by Type, 2021 (%)
- Vacuum-Assisted
- Fine Needle
- Core Needle
Global Needle Based Biopsy Gun Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Needle Based Biopsy Gun Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Needle Based Biopsy Gun Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Needle Based Biopsy Gun Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Needle Based Biopsy Gun revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Needle Based Biopsy Gun revenues share in global market, 2021 (%)
- Key companies Needle Based Biopsy Gun sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Needle Based Biopsy Gun sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- C. R. Bard
- Becton Dickinson and Company
- Cook Group Incorporated
- Leica Biosystems
- Argon Medical Devices
- B. Braun Melsungen
- Cardinal Health
- Olympus Corporation
- Boston Scientific Corporation
- FUJIFILM Holdings Corporation
Industry Market Size
